These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19371745)

  • 1. Local perfusion of corticosterone in the rat medial hypothalamus potentiates D-fenfluramine-induced elevations of extracellular 5-HT concentrations.
    Feng N; Telefont M; Kelly KJ; Orchinik M; Forster GL; Renner KJ; Lowry CA
    Horm Behav; 2009 Jun; 56(1):149-57. PubMed ID: 19371745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local inhibition of organic cation transporters increases extracellular serotonin in the medial hypothalamus.
    Feng N; Mo B; Johnson PL; Orchinik M; Lowry CA; Renner KJ
    Brain Res; 2005 Nov; 1063(1):69-76. PubMed ID: 16266691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organic cation transporter inhibition increases medial hypothalamic serotonin under basal conditions and during mild restraint.
    Feng N; Lowry CA; Lukkes JL; Orchinik M; Forster GL; Renner KJ
    Brain Res; 2010 Apr; 1326():105-13. PubMed ID: 20171957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
    Raiteri M; Bonanno G; Vallebuona F
    J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo correlates of central serotonin function after high-dose fenfluramine administration.
    Baumann MH; Ayestas MA; Rothman RB
    Ann N Y Acad Sci; 1998 May; 844():138-52. PubMed ID: 9668672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain.
    Rothman RB; Jayanthi S; Wang X; Dersch CM; Cadet JL; Prisinzano T; Rice KC; Baumann MH
    Synapse; 2003 Dec; 50(3):233-9. PubMed ID: 14515341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local inhibition of uptake
    Hassell JE; Collins VE; Li H; Rogers JT; Austin RC; Visceau C; Nguyen KT; Orchinik M; Lowry CA; Renner KJ
    Neurosci Lett; 2019 May; 701():119-124. PubMed ID: 30776492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission.
    Gasser PJ; Lowry CA; Orchinik M
    J Neurosci; 2006 Aug; 26(34):8758-66. PubMed ID: 16928864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-Chloroamphetamine- and d-fenfluramine-induced brain serotonin release in experimental portal-systemic encephalopathy.
    Bergqvist PB; Hjorth S; Wikell C; Apelqvist G; Bengtsson F
    Metab Brain Dis; 1997 Sep; 12(3):229-36. PubMed ID: 9346471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain.
    Gasser PJ; Orchinik M; Raju I; Lowry CA
    J Comp Neurol; 2009 Feb; 512(4):529-55. PubMed ID: 19025979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intact dopaminergic system is required for context-conditioned release of 5-HT in the nucleus accumbens of postweaning isolation-reared rats.
    Fulford AJ; Marsden CA
    Neuroscience; 2007 Oct; 149(2):392-400. PubMed ID: 17869434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis monitoring of variations in extracellular levels of serotonin, GABA and excitatory amino acids in the frontal cortex of awake rats in response to a single peripheral or central administration of dexfenfluramine.
    Rocher C; Bert L; Robert F; Trouvin JH; Renaud B; Jacquot C; Gardier AM
    Brain Res; 1996 Oct; 737(1-2):221-30. PubMed ID: 8930369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on plasma corticosterone levels and brain serotonin from interference with methamphetamine-induced corticosterone release in neonatal rats.
    Schaefer TL; Grace CE; Gudelsky GA; Vorhees CV; Williams MT
    Stress; 2010 Nov; 13(6):469-80. PubMed ID: 20666642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis.
    Lavicky J; Dunn AJ
    J Neurosci Res; 1995 Feb; 40(3):407-13. PubMed ID: 7745636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.
    Baumann MH; Ayestas MA; Dersch CM; Brockington A; Rice KC; Rothman RB
    Synapse; 2000 May; 36(2):102-13. PubMed ID: 10767057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of systemic phenylpropanolamine and fenfluramine on serotonin activity within rat paraventricular hypothalamus.
    McMahon LR; Wellman PJ
    Physiol Behav; 1996 Jan; 59(1):63-9. PubMed ID: 8848492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. d-fenfluramine, but not d-norfenfluramine, uses calcium to increase extracellular serotonin.
    Puig de Parada M; Parada MA; Pothos E; Hoebel BG
    Life Sci; 1995; 56(22):PL415-20. PubMed ID: 7746089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
    Tao R; Fray A; Aspley S; Brammer R; Heal D; Auerbach S
    Eur J Pharmacol; 2002 Jun; 445(1-2):69-81. PubMed ID: 12065196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (+)-Fenfluramine and its major metabolite, (+)-norfenfluramine, are potent substrates for norepinephrine transporters.
    Rothman RB; Clark RD; Partilla JS; Baumann MH
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1191-9. PubMed ID: 12649307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.